ArticleThe Journal of clinical investigation2012

Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.

Maria Grazia Ruocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.